Form 4: Clene Inc. Director Vallerie McLaughlin Acquires Stock Options
SEC Form 4
Director Vallerie McLaughlin acquired 2,815 stock options in Clene Inc. on October 2, 2024, at an exercise price of $4.89 per share, which vest immediately.
Summary
- Vallerie McLaughlin, a director of Clene Inc., reported a transaction on October 2, 2024, where she acquired 2,815 stock options.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- The exercise price for the options is $4.89 per share.
- The options vest immediately upon grant and expire on October 1, 2034.
- Following the transaction, McLaughlin directly owns 2,815 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
This is a standard Form 4 filing, reflecting insider transactions. Option grants are a common form of executive compensation in the biotechnology industry.
Stakeholder Impact
- The transaction could have a minor impact on shareholders by potentially diluting equity if the options are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of transaction: Vallerie McLaughlin acquired stock options. |
| 10/01/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.